Health and Fitness Health and Fitness
Wed, October 27, 2010
[ Wed, Oct 27th 2010 ] - Market Wire
PATIENT HOME MONITORING ANNOUNCES THE NOMINATION OF ADDITIONAL MEMBERS TO THE BOARD OF DIRECTORS
[ Wed, Oct 27th 2010 ] - Market Wire
Salix Pharmaceuticals Launches Corporate Twitter Account and Facebook Page
[ Wed, Oct 27th 2010 ] - Market Wire
BioCrysta?s Partner Shionogi Receives Approval for Pediatric Use Of Peramivir in Japan
[ Wed, Oct 27th 2010 ] - Market Wire
Santarus to Hold Third Quarter 2010 Financial Results Conference Call on November 8
Tue, October 26, 2010
[ Tue, Oct 26th 2010 ] - Market Wire
Response Genetics, Inc. Announces Departure of Chief Operating Officer
[ Tue, Oct 26th 2010 ] - Market Wire
Kindred Healthcare to Present at the Oppenheimer 21st Annual Healthcare Conference
[ Tue, Oct 26th 2010 ] - Market Wire
IPC The Hospitalist Company CEO Dr. Adam Singer Named MGMA-ACMPE Physician Executive of the Year
[ Tue, Oct 26th 2010 ] - Market Wire
Capsalus Corp. Invests in Nationally-Recognized aSocial Helpinga Network
[ Tue, Oct 26th 2010 ] - Market Wire
CIGNA Announces Appearance at the Oppenheimer 21st Annual Healthcare Conference
[ Tue, Oct 26th 2010 ] - Market Wire
ArQule, Inc. to Present at Oppenheimer 21st Annual Healthcare Conference
[ Tue, Oct 26th 2010 ] - Market Wire
PPD Reports Third Quarter 2010 Financial Results
[ Tue, Oct 26th 2010 ] - Market Wire
Incyte to Report Third Quarter 2010 Financial Res .. ug Discovery & Development Programs on November 9
[ Tue, Oct 26th 2010 ] - Market Wire
GTx Announces Proposed Public Offering of Common Stock
[ Tue, Oct 26th 2010 ] - Market Wire
Illumina Announces HiSeq 1000 Sequencing System
[ Tue, Oct 26th 2010 ] - Market Wire
Allos Therapeutics to Report Third Quarter 2010 Financial Results on November 4, 2010
[ Tue, Oct 26th 2010 ] - Market Wire
Healthways and BlueCross BlueShield of Tennessee .. mprove Health, Well-Being of Seniors in the State
[ Tue, Oct 26th 2010 ] - Market Wire
Cubist Pharmaceuticals to Present at November Investor Conferences
[ Tue, Oct 26th 2010 ] - Market Wire
STERIS Corporation to Announce Fiscal 2011 Second Quarter Earnings on November 3, 2010
[ Tue, Oct 26th 2010 ] - Market Wire
CORRECTING and REPLACING Amedisys Reports Third Q .. arter Revenue and Earnings, Updates 2010 Guidance
[ Tue, Oct 26th 2010 ] - Market Wire
ARIAD Announces Pricing of Public Offering of Common Stock
[ Tue, Oct 26th 2010 ] - Market Wire
PPD and Bend Research Enter into Collaboration to .. ion Development and Analytical Testing Capabiliti
[ Tue, Oct 26th 2010 ] - Market Wire
PPD and VirtualScopics Establish Strategic Alliance for Medical Imaging Services
[ Tue, Oct 26th 2010 ] - Market Wire
Obagi Medical Products Announces Proposed Seconda .. ockholders and Authorization to Repurchase Shares
[ Tue, Oct 26th 2010 ] - Market Wire
International Stem Cell Corporation Announces Com .. uring Run of Lifeline Skin Carea?s Stem Cell-Base
[ Tue, Oct 26th 2010 ] - Market Wire
BioSante Pharmaceuticals, Inc. To Present at Two Upcoming Investor Conferences
[ Tue, Oct 26th 2010 ] - Market Wire
MDS Inc. Completes Name Change to Nordion Inc., and Corresponding Change to Stock Ticker Symbols
[ Tue, Oct 26th 2010 ] - Market Wire
Life Technologies Establishes New Standard for Single-Read Accuracy in Next Generation Sequencing
[ Tue, Oct 26th 2010 ] - Market Wire
Biogen Idec Reports Third Quarter 2010 Results
[ Tue, Oct 26th 2010 ] - Market Wire
Exelixis Announces November 4 Webcast of Third Quarter 2010 Financial Results Conference Call
[ Tue, Oct 26th 2010 ] - Market Wire
Enzon to Release Third Quarter 2010 Earnings on Tuesday, November 2, 2010

Enzon to Release Third Quarter 2010 Earnings on Tuesday, November 2, 2010


Published on 2010-10-26 04:45:55 - Market Wire
  Print publication without navigation


BRIDGEWATER, N.J.--([ BUSINESS WIRE ])--Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) announced today that it will report its financial results for the quarter ended September 30, 2010, on Tuesday, November 2, 2010. The Company will also conduct a conference call that day at 4:00 p.m. ET to discuss results and highlights of the third quarter 2010.

All interested parties may access the call with the following information:

Domestic Dial-In Number: (877) 561-2748
International Dial-In Number: (720) 545-0044
Access Code: Enzon

The call will also be available via live audio webcast on the Enzon website, by going to the aCalendar of Eventsa™ page in the aInvestorsa™ section. Listeners should go to the website at least fifteen minutes before the event to download and install any necessary audio software. For those unable to attend the live audio webcast, a replay will be available beginning approximately one hour after the event. Additionally, a telephonic rebroadcast will also be available following the call. The rebroadcast will begin on Tuesday, November 2, 2010 at approximately 8:00 pm Eastern Time (ET) and end on Tuesday, November 9, 2010 at approximately 11:59 pm Eastern Time (ET). It may be accessed using the following information:

Domestic Dial-In Number: (800) 642-1687
International Dial-In Number: (706) 645-9291
Conference I.D.: 21014444

About Enzon

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development of innovative medicines for patients with cancer. Enzon's drug development programs utilize several approaches, including its cutting-edge proprietary customized linker-enhanced PEGylation technology and mRNA antagonists using the Locked Nucleic Acid (LNA) technology. Enzon receives a royalty revenue stream from licensing arrangements for other products developed using the proprietary PEGylation technology. Further information about Enzon and this press release can be found on the Company's web site at [ www.enzon.com ].

Contributing Sources